Jubilant Ingrevia to acquire 40% stake in Zettaone for ₹189.2 Cr
Jubilant Ingrevia will acquire a 40% stake in Zettaone Technologies for ₹189.2 crore. This strategic move aims to bolster its presence in the EDMS sector. The acquisition will occur in two tranches, with completion expected by November 2026 and September 2027.
The acquisition represents a significant strategic investment into a new and growing sector (EDMS) for Jubilant Ingrevia, with a substantial financial outlay. This move has the potential to fundamentally alter the company's business profile and revenue streams in the long term, thus having a high impact.
The acquisition of a strategic stake in Zettaone Technologies is presented as a growth-oriented move aligned with the company's 'Pinnacle growth strategy', aiming to strengthen its position in the electronics and semiconductor space and create long-term value. This indicates a positive outlook for future business development.
Jubilant Ingrevia Limited has entered into a binding term sheet with Zettaone Technologies India Private Limited for the acquisition of a 40% strategic equity stake. This acquisition, valued at approximately ₹189.2 crore, is expected to make Zettaone an associate company of Jubilant Ingrevia upon completion. The investment aligns with Jubilant Ingrevia's Pinnacle growth strategy, aiming to establish a strong platform in the Electronics Development and Manufacturing Services (EDMS) space. This move will enable the company to offer an integrated value proposition in the electronics and semiconductor sector, leveraging its existing manufacturing and customer-centric capabilities from its CDMO business.
Zettaone Technologies is an integrated electronics design and manufacturing platform with capabilities spanning R&D, design, prototyping, manufacturing, assembly, and box build, serving sectors like Aerospace, Defence, Semiconductor, Automotive, Medical, and Industrial. The company's turnover for the last three fiscal years was ₹51.1 crore (FY23-24), ₹79.1 crore (FY24-25), and ₹98.1 crore (FY25-26).
The acquisition will be completed in two tranches. The first tranche is anticipated to close by November 2026, with the second tranche expected by September 2027. This strategic move is intended to strengthen Jubilant Ingrevia's engagement across the electronics and semiconductor value chain and create long-term, sustainable value.
What to do with a filing like this
Jubilant Ingrevia Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jubilant Ingrevia Limited. Read the original for the full detail.